Style | Citing Format |
---|---|
MLA | Ziamajidi N, et al.. "Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study." Journal of Obstetrics, Gynecology and Cancer Research, vol. 9, no. 6, 2024, pp. 634-641. |
APA | Ziamajidi N, Moini N, Danesh H, Abbasalipourkabir R, Radnia N, Barartabar Z (2024). Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study. Journal of Obstetrics, Gynecology and Cancer Research, 9(6), 634-641. |
Chicago | Ziamajidi N, Moini N, Danesh H, Abbasalipourkabir R, Radnia N, Barartabar Z. "Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study." Journal of Obstetrics, Gynecology and Cancer Research 9, no. 6 (2024): 634-641. |
Harvard | Ziamajidi N et al. (2024) 'Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study', Journal of Obstetrics, Gynecology and Cancer Research, 9(6), pp. 634-641. |
Vancouver | Ziamajidi N, Moini N, Danesh H, Abbasalipourkabir R, Radnia N, Barartabar Z. Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study. Journal of Obstetrics, Gynecology and Cancer Research. 2024;9(6):634-641. |
BibTex | @article{ author = {Ziamajidi N and Moini N and Danesh H and Abbasalipourkabir R and Radnia N and Barartabar Z}, title = {Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study}, journal = {Journal of Obstetrics, Gynecology and Cancer Research}, volume = {9}, number = {6}, pages = {634-641}, year = {2024} } |
RIS | TY - JOUR AU - Ziamajidi N AU - Moini N AU - Danesh H AU - Abbasalipourkabir R AU - Radnia N AU - Barartabar Z TI - Epidemiological and Pathological Factors in Breast Cancer Patients in Tehran-Iran: A Single-Centered, Retrospective Study JO - Journal of Obstetrics, Gynecology and Cancer Research VL - 9 IS - 6 SP - 634 EP - 641 PY - 2024 ER - |